Open Access

Relation of four nontraditional lipid profiles to diabetes in rural Chinese H-type hypertension population

  • Haoyu Wang1,
  • Xiaofan Guo1,
  • Yintao Chen1,
  • Zhao Li1,
  • Jiaqi Xu1 and
  • Yingxian Sun1Email author
Lipids in Health and Disease201716:199

https://doi.org/10.1186/s12944-017-0590-7

Received: 6 June 2017

Accepted: 4 October 2017

Published: 11 October 2017

Abstract

Background

Mounting evidence suggested that nontraditional lipid profiles have been recognized as a reliable indicator for unfavorable cardiovascular events. The purpose of this study was to explore the role of nontraditional lipid profiles as potential clinical indices for the assessment of prevalent diabetes in rural Chinese H-type hypertension population.

Methods

During 2012 to 2013, we conducted a large cross-sectional study of 2944 H-type hypertension participants (≥35 years of age) from rural areas in northeast China. Subjects underwent accurate assessment of lipid profiles, fasting plasma glucose (FPG), homocysteine (Hcy) according to standard protocols.

Results

The proportion of diabetes showed a graded and linear increase across the quartiles for all four nontraditional lipid parameters. Nontraditional lipid variables were independent determinants of FPG, and its correlation for TG/HDL-C was strongest, whether potential confounders were adjusted or not. Multivariable logistic regression analysis established that the highest triglycerides (TG)/ high-density lipoprotein cholesterol (HDL-C) quartile manifested the largest ORs of prevalent diabetes (OR: 3.275, 95%CI: 2.109–5.087) compared with the lowest quartile. The fully adjusted ORs (95%CI) were 2.753 (1.783–4.252), 2.178 (1.415–2.351), 1.648 (1.097–2.478) for the top quartile of total cholesterol (TC)/HDL-C, low-density lipoprotein cholesterol (LDL-C)/HDL-C, and non-high-density lipoprotein cholesterol (non-HDL-C), respectively. On the basis of the area under receiver-operating characteristic curve (AUC), TG/HDL-C showed the optimal discriminating power for diabetes (AUC: 0.684, 95% CI: 0.650–0.718).

Conclusions

Nontraditional lipid profiles (TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C) were all consistently and independently correlated with prevalent diabetes among the H-type hypertension population in rural China. TG/HDL-C was prone to be more profitable in assessing the risk of prevalent diabetes and should be encouraged as an effective clinical tool for monitoring and targeted intervention of diabetes in H-type hypertension adults.

Keywords

H-type hypertension Lipid ratios Diabetes Lipids Rural population

Background

Hypertension is recognized as one of the major causes of cardiovascular disease (CVD) and mortality in worldwide [1]. In China, it has been regarded as the second most common leading risk factor of disability-adjusted life-years and deaths [2]. H-type hypertension is the concept of the concurrence of hypertension and high homocysteine (HHcy) by its concentration ≥ 10 μmol/L [35]. A multi-community, randomized study from the China Stroke Primary Prevention Trial revealed that H-type hypertension accounted for 80.3% of the hypertensive patients in 20,702 adults [6]. Previous studies suggested that H-type hypertension has been proposed to be an independent risk factor for carotid atherosclerotic plaques and cardio-cerebrovascular events [3, 4, 79]. The dramatically increasing prevalence of H-type hypertension is a great challenge to public health concerns and constitutes a serious socioeconomic burden. It was well-known that diabetes, being equivalent to the risk of coronary heart disease (CHD), is a major contributor to CVD and stroke [10, 11]. Clinical observations suggested that hypertensive subjects with elevated Hcy levels were positively linked with insulin resistance and the development of diabetes [1215]. The association of H-type hypertension with diabetes might be relevant for a synergistic risk for vascular diseases. Hence, identifying risk factors with regard to diabetes in H-type hypertension population could help improve population-based strategies for screening and prevention of subjects who are predisposed to be at increased risk of vascular complications.

Traditional lipid parameters, represented by decreased high-density lipoprotein cholesterol (HDL-C) and hypertriglyceridemia, has been confirmed to be a common finding in individuals with diabetes [1618]. Studies have proved that better control of dyslipidemia show favorable effect on vascular disease and related cardiovascular mortality in the subjects with diabetes [19, 20]. It has recently been proposed that nontraditional lipid profiles are powerful predictor for cardio-cerebrovascular diseases [2125]. For instance, TG/HDL-C represents a highly atherogenic marker of insulin resistance and cardiometabolic risk, which correlates positively with LDL phenotype B and LDL particle concentration, and inversely with small dense LDL particle size [24, 26]. The role of triglyceride (TG)/HDL-C in relation to cardiovascular disorders and mortality has been well documented [21, 22, 27, 28]. Moreover, total cholesterol (TC)/HDL-C, low-density lipoprotein cholesterol (LDL-C)/HDL-C, and non-HDL-C have found to be independent indicator of vascular risk with greater predictive value than isolated lipid levels [2325, 29]. Nevertheless, the association of nontraditional lipid parameters with diabetes remains unsettled. To date, the positive relationship of TG/HDL-C with diabetes has been indentified in a few prospective studies [3033], whereas one survey reported that the influence of TG/HDL on diabetes occurrence has been poor [34]. Apart from this, epidemiological evidence revealed that participants with elevated TC/HDL-C and non-HDL-C levels had a more unfavorable chance of developing diabetes [35, 36]. However, nontraditional lipid profiles and its association with diabetes in H-type hypertension population have not been investigated.

In this scenario, to highlight the clinical significance of nontraditional lipid indices (TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, non-HDL-C) in developing stages of cardio-cerebrovascular events, our current study aims to evaluate whether nontraditional lipid profiles were capable of identifying diabetes among hypertensive adults with HHcy levels in rural China. We also compared the attributes of four nontraditional lipid variables and attempted to determine the extent to which parameter is an optimal surrogate for identifying diabetic subjects who are more likely to be at increased risk of cardio-cerebrovascular disease.

Methods

Study population

The data originated from a large population-based epidemiological cross-sectional study of 11,956 permanent residents (age ≥ 35) in rural areas of China. The full details regarding the study design and definitions were extensively described elsewhere [3739]. This study enrolled 2944 H-type hypertension participants with complete data on nontraditional lipid variables and diabetes. The Ethics Committee of China Medical University (Shenyang, China) approved the study protocol. Each participant was contacted and informed in advance to know the purpose and procedure of survey before obtaining written informed consent.

Data collection and measurements

The detailed process about data collection and methods selection of this sample has been completely illuminated in our prior publications [3739]. All subjects fulfilled a structured questionnaire regarding on demographic characteristics, socioeconomic data, lifestyle risk factors, medical history of stroke and CVD, and medication used in the past two weeks with the assistance of cardiologists and trained nurses.

Based on the recommended AHA’s protocol, after each subject had been resting at least 5 min, blood pressure (BP) were measured by trained observer in a sitting position. The three consecutive measurements were collected on the right arm at 2-min intervals and the average value was recorded for analysis.

Anthropometric assessments were acquired including items of weight, height, and waist circumference (WC). Height and weight were accurate to 0.1 cm and 0.1 kg, respectively with the individuals wearing light clothing and bare feet. WC was measured by placing an inelastic tape metre in umbilical level at minimal respiration. Body mass index (BMI) was calculated as weight/height2 (kg/m2).

After an overnight fasting with 12 h, the Blood sample was drawn from each participant antecubital vein in the morning for assessing fasting plasma glucose (FPG), serum creatinine (SCr), TC, TG, LDL-C, and HDL-C. Details of Storage process and laboratory measurement methods were available in the previous publications [3739]. Plasma Hcy was measured by enzymatic cycling assay (Hitachi, Japan). Non-HDL-C levels were determined by subtracting serum HDL-C levels from TC [30, 35]. TG/HDL-C, TC/HDL-C, LDL-C/HDL-C were measured as TG, TC, LDL-C divided by HDL-C.

Definitions

According to the JNC-7 report [40], diagnosis of hypertension was established as an average systolic blood pressure (SBP) at least 140 mmHg or/and diastolic blood pressure (DBP) ≥90 mmHg or individuals who were on antihypertensive medications or self-reported previous diagnosed hypertension. The definition of diabetes was determined as follows: fasting glucose greater than or equal to 7.0 mmol/L or self-reported medical diagnosis history or receiving plasma glucose lowering therapy in the light of American Diabetes Association criteria [41]. HHcy was identified by the concentration of Hcy ≥10 mmol/L [42, 43]. Individuals with concomitant hypertension and HHcy were defined as having H-type hypertension [3, 5].

Statistical analyses

The H-type hypertension population is expressed as the means with standard deviations (SDs) or numbers with percentages. Comparisons between individuals stratified by diabetes were assessed with Student’s t-test to examine differences in means, while Chi-squared test for independence was utilized to compare differences of categorical variables in proportions. Each of non-traditional lipid profile was stratified into quartiles in accordance with the distribution of lipid variables. The chi-square linear-by-linear association test was analyzed to test for linear trends across the quartile groups of nontraditional lipid parameters for proportions of diabetes. Pearson’s correlation analysis regarding the association of two variables was performed. The relationship of nontraditional lipid parameters with FPG levels as a continuous variable was evaluated by stepwise multivariate regression analysis, which is expressed through standardized regression coefficient. We conducted the logistic regression analyses to evaluate the odds ratios (ORs) and corresponding 95% confidence intervals (CIs) of prevalent diabetes in H-type hypertension population by the quartiles of TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, and non-HDL-C with adjustment for various confounding risk factors. The receiver-operating characteristic (ROC) curve was employed to determine the predictive value of each nontraditional four lipid profiles on diabetes. Assessing the discrimination ability of nontraditional lipid variables in detecting diabetes was performed by the area under the ROC curve (AUC). All of the statistical analyses involved the application of SPSS software, version 22.0 (IBM Corp), and a two-tailed P < 0.05 was adopted to be statistically significant.

Results

Clinical and demographic characteristics of H-type hypertension population recruited in this survey, as stratified by diabetes status, are presented in Table 1. A total of 2944 individuals (1960 males and 984 females) were included in the present study, with 272 cases (9.2%) of diabetes identified. The average age of participants with diabetes was 59.84 years (SD = 9.85), 3 year older than the rest of the participants. When compared to subjects without prevalent diabetes, the diabetes group were more likely to be low physical activity, higher BMI, and higher WC (P < 0.05). The mean values of SBP and DBP were remarkably elevated in those with diabetes than those without (P < 0.001). The participants with diabetes exhibited significantly higher levels of TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, and non-HDL-C (P < 0.001). Additionally, participants with diabetes had a higher prevalence of the history of stroke, cardiovascular disease and medication used.
Table 1

Characteristics of H-type hypertension population with or without diabetes

Variables

Total (n = 2944)

Non-diabetes (n = 2672)

Diabetes (n = 272)

P value

Age (years)

57.09 ± 11.29

56.81 ± 11.39

59.84 ± 9.85

<0.001

Male (%)

1960 (66.6)

1789 (67.0)

171 (62.9)

0.174

Race

   

0.065

 Han (%)

2751 (93.4)

2504 (93.7)

247 (90.8)

 

 Others (%)

193 (6.6)

168 (6.3)

25 (9.2)

 

Education

   

0.231

 low

1529 (51.9)

1375 (51.5)

154 (56.6)

 

 middle

1147 (39.0)

1049 (39.3)

98 (36.0)

 

 high

268 (9.1)

248 (9.3)

20 (7.4)

 

Family income (CNY/year)

   

0.340

 ≤ 5000

652 (22.1)

590 (22.1)

62 (22.8)

 

 5000–20,000

1648 (56.0)

1506 (56.4)

142 (52.2)

 

 > 20,000

644 (21.9)

576 (21.6)

68 (25.0)

 

Physical activity

   

0.021

 low

2559 (86.9)

2337 (87.5)

222 (81.6)

 

 moderate

290 (9.9)

251 (9.4)

39 (14.3)

 

 high

95 (3.2)

84 (3.1)

11 (4.0)

 

 Current smoking status (%)

1429 (48.5)

1306 (48.9)

123 (45.2)

0.250

 Current drinking status (%)

882 (30.0)

793 (29.7)

89 (32.7)

0.297

 Diet score

2.26 ± 1.17

2.27 ± 1.17

2.20 ± 1.17

0.392

 BMI (kg/m2)

24.75 ± 3.71

24.60 ± 3.70

26.21 ± 3.52

<0.001

 WC (cm)

84.24 ± 9.88

83.74 ± 9.83

89.17 ± 9.01

<0.001

 SBP (mmHg)

147.09 ± 25.58

145.88 ± 25.19

158.94 ± 26.37

<0.001

 DBP (mmHg)

83.37 ± 12.46

83.08 ± 12.34

86.26 ± 13.30

<0.001

 SCr (mmol/L)

75.74 ± 28.34

75.60 ± 218.88

77.70 ± 22.33

0.407

 FPG (mmol/L)

5.82 ± 1.56

5.46 ± 0.57

9.29 ± 3.17

<0.001

 TG (mmol/L)

1.38 ± 1.59

1.28 ± 1.33

2.35 ± 2.99

<0.001

 TC (mmol/L)

3.79 ± 1.14

3.72 ± 1.06

4.40 ± 1.62

<0.001

 LDL-C (mmol/L)

2.14 ± 0.76

2.11 ± 0.73

2.45 ± 0.90

<0.001

 HDL-C (mmol/L)

1.43 ± 0.44

1.45 ± 0.44

1.30 ± 0.42

<0.001

 TG/HDL-C ratio (mmol/L)

1.38 ± 1.59

1.28 ± 1.33

2.35 ± 2.99

<0.001

 TC/HDL-C ratio (mmol/L)

3.79 ± 1.14

3.72 ± 1.06

4.40 ± 1.62

<0.001

 LDL-C/HDL-C ratio (mmol/L)

2.14 ± 0.76

2.11 ± 0.73

2.45 ± 0.90

<0.001

 non-HDL-C (mmol/L)

3.66 ± 0.99

3.62 ± 0.97

4.04 ± 1.10

<0.001

 History of stroke (%)

350 (12.2)

289 (11.1)

61 (22.8)

<0.001

 History of CVD (%)

451 (15.7)

384 (14.7)

67 (25.1)

<0.001

 Medication used a (%)

1658 (56.3)

1479 (55.4)

179 (65.8)

0.001

Data are expressed as the mean (SD) or as n (%). CNY, China Yuan (1CNY = 0.154 USD).

BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, non-HDL-C non-high-density lipoprotein cholesterol, SCr serum creatinine, CVD cardiovascular disease

aIndicating any self-reported medication used in the past two weeks

Figure 1 summarized the prevalence of diabetes in hypertensive participants with HHcy according to quartiles of nontraditional lipid parameters. Across the increasing quartiles of all nontraditional lipid variables, we found a significantly escalating linear trend in the proportion of diabetes (all P for trend <0.001). The prevalence of diabetes in H-type hypertension population increased 4.0-fold, 3.3-fold, 3.1-fold, 2.6-fold higher in the highest TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C group than in the lowest groups respectively.
Fig. 1

Prevalence of diabetes in H-type hypertension population by quartiles of TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C. A linear increasing trend across nontraditional lipid profiles quartile groups was observed

As shown in Table 2, univariate correlation analysis revealed that TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C manifested significant positive correlations with FPG (all P < 0.001). FPG was also associated with age, physical activity, BMI, WC, SDP, DBP, history of stroke and CVD (all P < 0.05). By performing stepwise multivariate regression analysis, we found that all nontraditional lipid variables were still independent determinants of FPG in H-type hypertension population even after further adjustment for a broad array of potential confounders (all P < 0.001). The high values for standardized regression coefficient are indicative of strong correlations, which meant TG/HDL-C was the strongest variable that interacted independently on FPG.
Table 2

Pearson’s correlation and stepwise multivariate regression analysis of nontraditional lipid profiles and fasting plasma glucose in subjects with H-type hypertension

Variables

FPG (mmol/L)

   

Model 1

Model 2

Model 3

Model 4

 

r

P value

β

P value

β

P value

β

P value

β

P value

Age

0.104

<0.001

0.073

<0.001

0.054

0.006

0.049

0.017

0.049

0.014

Sex

−0.007

NS

NI

 

NI

 

NI

 

NI

 

Race

0.014

NS

NI

 

NI

 

NI

 

NI

 

Education

−0.028

NS

NI

 

NI

 

NI

 

NI

 

Family income

−0.013

NS

NI

 

NI

 

NI

 

NI

 

Physical activity

0.048

0.009

NS

NS

NS

NS

Current smoking status

−0.026

NS

NI

 

NI

 

NI

 

NI

 

Current drinking status

0.035

NS

NI

 

NI

 

NI

 

NI

 

Diet score

−0.025

NS

NI

 

NI

 

NI

 

NI

 

BMI

0.097

<0.001

NS

NS

−0.061

0.042

NS

WC

0.152

<0.001

0.094

<0.001

0.083

<0.001

0.142

<0.001

0.104

<0.001

SBP

0.152

<0.001

0.097

<0.001

0.108

<0.001

0.104

<0.001

0.095

<0.001

DBP

0.108

<0.001

NS

NS

NS

NS

Scr

0.022

NS

NI

 

NI

 

NI

 

NI

 

TG

0.187

<0.001

NI

 

NI

 

NI

 

NI

 

TC

0.117

<0.001

NI

 

NI

 

NI

 

NI

 

LDL-C

0.091

<0.001

NI

 

NI

 

NI

 

NI

 

HDL-C

−0.086

<0.001

NI

 

NI

 

NI

 

NI

 

History of stroke

0.086

<0.001

NS

NS

NS

NS

History of CVD

0.068

<0.001

0.042

0.021

0.037

0.047

0.043

0.021

0.043

0.021

Medication used

0.033

NS

NI

 

NI

 

NI

 

NI

 

TG/HDL-C ratio

0.169

<0.001

0.142

<0.001

NI

 

NI

 

NI

 

TC/HDL-C ratio

0.173

<0.001

NI

 

0.129

<0.001

NI

 

NI

 

LDL-C/HDL-C ratio

0.148

<0.001

NI

 

NI

 

0.098

<0.001

NI

 

non-HDL-C

0.158

<0.001

NI

 

NI

 

NI

 

0.104

<0.001

R2

  

0.064

 

0.060

 

0.054

 

0.055

 

Variables were included in multivariate models when their p value was less than 0.05 in Pearson’s correlation; Model 1: age, physical activity, BMI, WC, SBP, history of stroke and CVD, TG/HDL-C ratio were considered as independent variables; Model 2: age, physical activity, BMI, WC, SBP, history of stroke and CVD, TC/HDL-C ratio were considered as independent variables; Model 3: age, physical activity, BMI, WC, SBP, history of stroke and CVD, LDL-C/HDL-C ratio were considered as independent variables; Model 4: age, physical activity, BMI, WC, SBP, history of stroke and CVD, non-HDL-C were considered as independent variables

Abbreviations: r correlation coefficient, β regression coefficient, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, SCr serum creatinine, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, non-HDL-C non-high-density lipoprotein cholesterol, CVD cardiovascular disease, NS not significant, NI, not included in the model

Table 3 revealed that the ORs and 95%CI for the presence of diabetes all showed a significant progressive increase across higher TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C levels in a dose-response fashion (all P for trend < 0.05). After multivariable adjustment, H-type hypertension subjects in the top quartile of TG/HDL-C had 3.3-fold increased odds of prevalent diabetes relative to those in the bottom quartile of TG/HDL-C (OR: 3.275, 95%CI: 2.109–5.087), while the smallest ORs for highest non-HDL-C quartile with regard to diabetes was 1.648 (95%CI: 1.097–2.478). Meanwhile, the ORs of prevalent diabetes increased by a factor of 2.8 for H-type hypertension individuals in the highest quartile of TC/HDL-C group (OR: 2.753, 95%CI: 1.783–4.252) as compared with the reference group. The association strength for prevalent diabetes in hypertensive adults with HHcy was slightly lower in the highest quartile of LDL-C/HDL-C group (OR: 2.178, 95%CI: 1.415–3.351).
Table 3

Odd ratios (95% CI) for diabetes in hypertensive participants with elevated homocysteine levels according to quartiles of nontraditional lipid profiles

Variables

Lipid measures

P for trend

 

Quartile 1

Quartile 2

Quartile 3

Quartile 4

TG/HDL-C ratio

≤0.59

0.59–0.92

0.92–1.55

>1.55

 

 Model 1

1.000 (reference)

1.094 (0.670–1.787)

2.552 (1.667–3.906)

4.604 (3.079–6.885)

<0.001

 Model 2

1.000 (reference)

1.020 (0.623–1.670)

2.420 (1.578–3.711)

4.574 (3.054–6.852)

<0.001

 Model 3

1.000 (reference)

0.955 (0.573–1.590)

2.044 (1.299–3.125)

3.275 (2.109–5.087)

<0.001

TC/HDL-C ratio

≤3.12

3.12–3.80

3.80–4.58

>4.58

 

 Model 1

1.000 (reference)

1.189 (0.757–1.868)

1.980 (1.310–2.993)

3.841 (2.619–5.634)

<0.001

 Model 2

1.000 (reference)

1.161 (0.738–1.826)

1.882 (1.243–2.850)

3.673 (2.501–5.396)

<0.001

 Model 3

1.000 (reference)

1.123 (0.702–1.797)

1.682 (1.079–2.621)

2.753 (1.783–4.252)

<0.001

LDL-C/HDL-C ratio

≤1.64

1.64–2.11

2.11–2.65

>2.65

 

 Model 1

1.000 (reference)

1.457 (0.948–2.239)

1.729 (1.141–2.618)

3.520 (2.403–5.156)

<0.001

 Model 2

1.000 (reference)

1.424 (0.925–2.190)

1.648 (1.087–2.500)

3.363 (2.292–4.933)

<0.001

 Model 3

1.000 (reference)

1.207 (0.769–1.894)

1.361 (0.874–2.120)

2.178 (1.415–3.351)

<0.001

non-HDL-C

≤3.11

3.11–3.71

3.71–4.43

>4.43

 

 Model 1

1.000 (reference)

1.203 (0.786–1.841)

1.830 (1.235–2.712)

2.832 (1.951–4.112)

<0.001

 Model 2

1.000 (reference)

1.143 (0.745–1.751)

1.723 (1.160–2.559)

2.571 (1.761–3.755)

<0.001

 Model 3

1.000 (reference)

0.902 (0.578–1.410)

1.315 (0.867–1.994)

1.648 (1.097–2.478)

0.002

Model 1: unadjusted; Model 2: adjusted for age and sex; Model 3: adjusted for all the factors in Model 2 and race, education level, family income, current smoking and drinking status, physical activity, diet score, body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, serum creatinine, history of stroke and cardiovascular disease (coronary heart disease, arrhythmia and heart failure), medication used

Abbreviations: OR odd ratio, 95% CI 95% confidence interval, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, non-HDL-C, non-high-density lipoprotein cholesterol

Table 4 showed the AUCs (and 95% CIs) of diabetes in relation to the four nontraditional lipid profiles. TG/HDL-C with highest AUC scores presented the best accuracy in predicting diabetes (AUC: 0.684, 95% CI: 0.650–0.718, P < 0.001), whereas non-HDL-C showed the lowest AUC value for diabetes (AUC: 0.621, 95% CI: 0.585–0.657, P < 0.001). Despite no significant difference was observed while comparing the predictive capability of LDL-C/HDL-C to non-HDL-C, the accuracy of detecting diabetes in H-type hypertensive adults was statistically different between either two of nontraditional lipid variables after comparisons of AUC (all P < 0.05).
Table 4

The area under the curve (AUC) of nontraditional lipid profiles for the presence of diabetes in H-type hypertension population

Variables

AUC

(95%CI)

P value

TG/HDL-C ratio

0.684

(0.650–0.718)a,b,c

<0.001

TC/HDL-C ratio

0.659

(0.624–0.693)b,c,d

<0.001

LDL-C/HDL-C ratio

0.623

(0.587–0.659)a,d

<0.001

non-HDL-C

0.621

(0.585–0.657)a,d

<0.001

Abbreviations: 95%CI 95% confidence interval, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, non-HDL-C non-high-density lipoprotein cholesterol

aIndicates a significant difference as compared to TC/HDL-C

bIndicates a significant difference as compared to LDL-C/HDL-C

cIndicates a significant difference as compared to non-HDL-C

dIndicates a significant difference as compared to TG/HDL-C

Discussion

In this large sample of community members, our main finding was that all nontraditional lipid profiles were significantly related to an increased risk for diabetes among rural H-type hypertension population in northeast China. FPG appeared to be correlated with nontraditional lipid profiles even after adjustment for the effect of covariates in multiple regression analysis. Positive and linear trend associations across increasing quartiles of nontraditional lipid parameters with the prevalence of diabetes were observed. Our study for the first time claimed that TG/HDL-C was thought to have a comparatively superior predictive ability in the identification of prevalent diabetes compared to TC/HDL-C, LDL-C/HDL-C, and non-HDL-C. To a greater importance, it was clear that detection of nontraditional lipid profiles might result beneficial for better prevention and control of diabetes in a large group of H-type hypertension adults.

Epidemiologic studies have demonstrated that lipoprotein abnormalities correlated independently with the presence of diabetes [16, 18, 44]. Lipid-lowering therapy has largely contributed to a better reduction of major vascular events and cardiovascular risk in patients with diabetes [20, 45]. Recently, nontraditional lipid profiles have become available to predict cardio-cerebrovascular disease for making clinical decisions in prospective studies, which communicate the higher risk for cardiometabolic disease progression at an early stage [2124, 27, 29]. Arsenault BJ and colleagues supported that independently of LDL-C, subjects with increased TC/HDL-C and non-HDL-C levels conferred an increased CHD risk [23]. Another study conducted in Asia proved the potential use of TG/HDL-C and TC/HDL-C for CVD risk prediction [22]. Moreover, LDL-C/HDL-C has been considered as a valuable and standard indicator for CVD with greater predictive effect than each parameter used independently [25, 46]. For instance, TC/HDL-C has been suggested as an indirect estimate of atherogenic lipoprotein particle concentration and size, which was not accessible in simple lipid variables [23, 29]. At present, the findings of a large cross-sectional study consisting of representative US civilian population sample described that combination of elevated Hcy and hypertension delivered a 12.0-fold and 17.3-fold higher risk of stroke in males and females, respectively [9]. It was worth noting that elevated homocysteine levels combined with hypertension had a substantially higher risk of developing early carotid artery atherosclerosis and cardio-cerebrovascular events [3, 79], as well as exerted a jointed effect with diabetes on the risk of stroke and CVD [1215]. Thus, it is conceivable that the H-type hypertensive subjects with diabetes are easily subjected to future risk of cardiovascular diseases and mortality. However, the role of nontraditional lipid variables with respect to the presence of diabetes among the hypertensive population with hyperhomocysteinemia has not been elucidated. Consequently, this large, contemporary population-based survey is initiated to analyze the influence of nontraditional lipid profiles on diabetes in large-scale H-type hypertension population of China.

A study based on city community found an independent contribution of per 1 SD increment in TG/HDL-C to prevalent diabetes (OR: 1.45, 95%CI: 1.31–1.60) [36]. Hadaegh et al. also found that there was positive association of TG/HDL-C with prevalent diabetes among Iranian population, and those with 1 SD change in TG/HDL-C were 1.4 times and 1.3 times more likely to have prevalent diabetes in females and males, respectively [30]. Similarly, a cohort study of Japanese community residents in that the risks of diabetes were significantly augmented with elevated TG/HDL-C levels in developed country [31]. In 687 participants from an urban community in China, TG/HDL-C had a significant difference in the risk prediction of diabetes occurrence with the ORs being 1.341 (p = 0.010) [47]. In accordance with their results, our study reported that participants with the highest TG/HDL-C levels conferred 3.3-fold greater odds of prevalent diabetes than those with the lowest quartile in H-type hypertension population. However, one prospective study showed a null association, which meant TG/HDL-C failed to predict the incidence of diabetes among high-risk individuals in Iran [34]. Inconsistent evidence from previous studies can be explained by the fact that the survey was performed in Iranian people who experienced a greater risk of diabetes occurrence, resulting from having first degree relatives of patients with diabetes.

The data from a Canada residents showed that there were pronounced effects of increased TC/HDL-C and non-HDL-C levels on odds of prevalent diabetes, and non-HDL-C was suggested to be the most useful marker of prevalent diabetes among other lipid profiles [35]. Consistently, our study confirmed that the independent and positive effect of TC/HDL-C and non-HDL-C on likelihood of diabetes in H-type hypertension adults, in which the accuracy of TC/HDL-C identifying diabetes was superior over non-HDL-C. Additional, there has been no relevant literature confirming a significant predictive value of LDL-C/HDL-C in relation to diabetes in hypertensive subjects with elevated homocysteine levels so far. Our study provided a novel insight that LDL-C/HDL-C provided a positive correlation with diabetes among H-type hypertension populations in China.

The mechanism by which the association between nontraditional lipid profiles and diabetes might be related arouses great interest. It was widely-accepted that lipotoxicity, inflammation, and endoplasmic reticulum (ER) stress can induce insulin resistance (IR) [4850]. Previous studies have revealed that high TG levels seem to give rise to a remarkable amount of fatty acids to be deposited in cells in ectopic lipid storage [51]. Unger RH, et al. indicated that hypertriglyceridemia has a highly significant association with lipotoxicity, which cause overload of free fatty acid (FFA) levels in the skeletal muscle and pancreatic islets, as well as lead to β-cell dysfunction, apoptosis, insulin resistance and diabetes [52]. Lipotoxicity is responsible for the main causal mechanism of IR [48, 49, 53]. Besides, dyslipidemia could directly promote inflammation or ER stress that serves as a possible causal factor of IR [16]. Moreover, low HDL-C levels may have a negative impact on glucose homeostasis through reducing insulin secretion, weakening insulin sensitivity, and impairing the process of glucose uptake by muscle via the AMP-activated protein kinase [53]. It has been shown that elevated LDL-C levels promote the loss of β-cells in spite of being impossible to modulate insulin sensitivity [54, 55]. IR is also a common pathway related to the formation of increased VLDL, as a component of non-HDL-C, and plasma FFA levels, which stimulates lipogenesis and cholesterol synthesis. Notably, the excess amounts of FFA are generated in adipose tissue and transferred to the liver, which brings about the raise production of VLDL and TG, increased clearance of HDL-C by kidney, and a decline of HDL-C levels under the influence of cholesterol ester transfer protein [56, 57]. Accordingly, it is obvious that dyslipidemia and IR form a vicious, reciprocal feedback cycle, and they may reinforce each other. This interaction accelerates the development of IR in the early stages of the development of diabetes.

Some limitations and strengths of the present study need to be mentioned when interpreting our results. Firstly, the cross-sectional design limits our capacity to make causal inference between nontraditional lipid parameters and diabetes in H-type hypertension population, so future longitudinal studies to investigate the potential role of CMI as a predictor are warranted. Secondly, we failed to collect information on vitamin B12, folic acid, and methylenetetrahydrofolate reductase (MTHFR) genotype, which would be possible confounders affecting H-type hypertension population. Furthermore, data on using fasting plasma glucose as the criterion for judging for the presence of diabetes has been extensively established in the large-scale epidemiological survey [58, 59], but our present study did not measure random blood glucose or hemoglobin A1c, which might reduce the accuracy of diagnosis of diabetes. Likewise, the absence of fasting insulin, HOMA-IR, and HOMA-Beta may reduce the possibility of screening all patients with diabetes. However, it is noteworthy that our population-based design for the first time confirms that nontraditional lipid profiles (TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, and non-HDL-C) make a valuable contribution to a much greater risk for diabetes in H-type hypertension population of rural China. These data are particularly meaningful in the case of hypertensive Chinese rural population with high homocysteine levels who are more prone to an increased risk of atherosclerosis and cardiovascular ischemic events. The advantages of using nontraditional lipid variables measurements are inexpensive and are easy to calculate in annual health examination.

Conclusions

In summary, our study revealed in H-type hypertension population of rural Northeast China that TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, and non-HDL-C were all positively and significantly associated with the risk of prevalent diabetes independent of relevant confounding factors. Also, TG/HDL-C appeared to outperform other nontraditional lipid parameters in determining the presence of diabetes. These results underscored the necessity of adopting nontraditional lipid parameters as a convenient indicator for clinical settings of diabetes in Chinese adults with H-type hypertension.

Abbreviations

AUC: 

Area under receiver-operating characteristic curve

BMI: 

Body mass index

CHD: 

Coronary heart disease

CVD: 

Cardiovascular disease

DBP: 

Diastolic blood pressure

ER: 

Endoplasmic reticulum

FPG: 

Fasting plasma glucose

Hcy: 

Homocysteine

HDL-C: 

High-density lipoprotein cholesterol

IR: 

Insulin resistance

LDL-C: 

Low-density lipoprotein cholesterol

non-HDL-C: 

Non-high-density lipoprotein cholesterol

OR: 

Odd ratio

SBP: 

Systolic blood pressure

SCr: 

Serum creatinine

SD: 

Standard deviation

TC: 

Total cholesterol

TG: 

Triglyceride

WC: 

Waist circumference

Declarations

Acknowledgements

Not applicable.

Funding

This study was supported by grants from the “Twelfth Five-Year” project funds (National Science and Technology Support Program of China, Grant #2012BAJ18B02) and the Natural Science Foundation of Liaoning Province (2013021090).

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Authors’ contributions

HW analyzed data and drafted the manuscript. XG, YC gave guidance on writing this paper. ZL and JX supervised the data collection during investigation. YS designed the research. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

The Ethics Committee of China Medical University (Shenyang, China) approved the study protocol. After all participants had been acquainted with the purpose and procedure of survey, we acquired written informed consent from each participant.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Cardiology, The First Hospital of China Medical University

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.View ArticlePubMedGoogle Scholar
  2. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, Wan X, Yu S, Jiang Y, Naghavi M, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010. Lancet. 2013;381:1987–2015.View ArticlePubMedGoogle Scholar
  3. Chen Z, Wang F, Zheng Y, Zeng Q, Liu H. H-type hypertension is an important risk factor of carotid atherosclerotic plaques. Clin Exp Hypertens. 2016;38:424–8.View ArticlePubMedGoogle Scholar
  4. Ye Z, Wang C, Zhang Q, Li Y, Zhang J, Ma X, Peng H, Lou T. Prevalence of Homocysteine-related hypertension in patients with chronic kidney disease. J Clin Hypertens (Greenwich). 2017;19:151–60.View ArticleGoogle Scholar
  5. DY H, XP X. Prevention of stroke relies on valid control “H” type hypertension. Zhonghua Nei Ke Za Zhi. 2008;47:976–7.Google Scholar
  6. Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, Tang G, Wang B, Chen D, He M, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35.View ArticlePubMedGoogle Scholar
  7. Zhang Z, Fang X, Hua Y, Liu B, Ji X, Tang Z, Wang C, Guan S, Wu X, Liu H, Gu X. Combined effect of Hyperhomocysteinemia and hypertension on the presence of early carotid artery atherosclerosis. J Stroke Cerebrovasc Dis. 2016;25:1254–62.View ArticlePubMedGoogle Scholar
  8. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010;298:153–7.View ArticlePubMedGoogle Scholar
  10. Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J. 2008;29:1889–95.View ArticlePubMedGoogle Scholar
  11. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829–41.View ArticleGoogle Scholar
  12. Wang C, Wu Q, Zhang L, Hao Y, Fan R, Peng X, Liu S, Chen Z, Zhang T, Chen S, et al. Elevated total plasma homocysteine levels are associated with type 2 diabetes in women with hypertension. Asia Pac J Clin Nutr. 2015;24:683–91.PubMedGoogle Scholar
  13. Ustundag S, Arikan E, Sen S, Esgin H, Ciftci S. The relationship between the levels of plasma total homocysteine and insulin resistance in uncomplicated mild-to-moderate primary hypertension. J Hum Hypertens. 2006;20:379–81.View ArticlePubMedGoogle Scholar
  14. Catena C, Colussi G, Nait F, Capobianco F, Sechi LA. Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. Am J Hypertens. 2015;28:943–50.View ArticlePubMedGoogle Scholar
  15. Pang H, Han B, Fu Q, Zong Z. Association of high homocysteine levels with the risk stratification in hypertensive patients at risk of stroke. Clin Ther. 2016;38:1184–92.View ArticlePubMedGoogle Scholar
  16. Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233:130–8.View ArticlePubMedGoogle Scholar
  17. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36:232–40.View ArticlePubMedGoogle Scholar
  18. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study. Arch Intern Med. 2007;167:1068–74.View ArticlePubMedGoogle Scholar
  19. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91.View ArticlePubMedGoogle Scholar
  20. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.View ArticlePubMedGoogle Scholar
  21. Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN, Sopko G. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's ischemia syndrome evaluation (WISE). Am Heart J. 2009;157:548–55.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Barzi F, Patel A, Woodward M, Lawes CM, Ohkubo T, Gu D, Lam TH, Ueshima H. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol. 2005;15:405–13.View ArticlePubMedGoogle Scholar
  23. Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55:35–41.View ArticlePubMedGoogle Scholar
  24. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–33.View ArticlePubMedGoogle Scholar
  25. Fernandez ML, Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr. 2008;27:1–5.View ArticlePubMedGoogle Scholar
  26. Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97:1007–9.View ArticlePubMedGoogle Scholar
  27. Drexel H, Aczel S, Marte T, Benzer W, Langer P, Moll W, Saely CH. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care. 2005;28:101–7.View ArticlePubMedGoogle Scholar
  28. Turak O, Afsar B, Ozcan F, Oksuz F, Mendi MA, Yayla C, Covic A, Bertelsen N, Kanbay M. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict new cardiovascular events in essential hypertensive patients. J Clin Hypertens (Greenwich). 2016;18:772–7.View ArticleGoogle Scholar
  29. Elshazly MB, Nicholls SJ, Nissen SE, St John J, Martin SS, Jones SR, Quispe R, Stegman B, Kapadia SR, Tuzcu EM, Puri R. Implications of Total to high-density lipoprotein cholesterol ratio discordance with alternative lipid parameters for coronary Atheroma progression and cardiovascular events. Am J Cardiol. 2016;118:647–55.View ArticlePubMedGoogle Scholar
  30. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis. 2010;9:85.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Fujihara K, Sugawara A, Heianza Y, Sairenchi T, Irie F, Iso H, Doi M, Shimano H, Watanabe H, Sone H, Ota H. Utility of the triglyceride level for predicting incident diabetes mellitus according to the fasting status and body mass index category: the Ibaraki prefectural health study. J Atheroscler Thromb. 2014;21:1152–69.View ArticlePubMedGoogle Scholar
  32. Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014;62:345–9.View ArticlePubMedGoogle Scholar
  33. Wang YL, Koh WP, Talaei M, Yuan JM, Pan A: Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women. 2016.Google Scholar
  34. Janghorbani M, Amini M. Utility of serum lipid ratios for predicting incident type 2 diabetes: the Isfahan diabetes prevention study. Diabetes Metab Res Rev. 2016;32:572–80.View ArticlePubMedGoogle Scholar
  35. Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ. Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab. 2012;14:821–5.View ArticlePubMedGoogle Scholar
  36. Song Q, Liu X, Wang A, Wang Y, Zhou Y, Zhou W, Wang X. Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study. Lipids Health Dis. 2016;15:70.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Sun GZ, Li Z, Guo L, Zhou Y, Yang HM, Sun YX. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults. Lipids Health Dis. 2014;13:189.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Li Z, Bai Y, Guo X, Zheng L, Sun Y, Roselle AM. Alcohol consumption and cardiovascular diseases in rural China. Int J Cardiol. 2016;215:257–62.View ArticlePubMedGoogle Scholar
  39. Zhang N, Chang Y, Guo X, Chen Y, Ye N, Sun Y. A body shape index and body roundness index: two new body indices for detecting association between obesity and hyperuricemia in rural area of China. Eur J Intern Med. 2016;29:32–6.View ArticlePubMedGoogle Scholar
  40. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.View ArticlePubMedGoogle Scholar
  41. Basevi V, Di Mario S, Morciano C, Nonino F, Magrini N. Standards of medical care in diabetes--2011. Diabetes Care. 2011;34 (Suppl 1):S11–61.Google Scholar
  42. Qin X, Huo Y. H-type hypertension, stroke and diabetes in China: opportunities for primary prevention. J Diabetes. 2016;8:38–40.Google Scholar
  43. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke: co-sponsored by the council on cardiovascular radiology and intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577–617.View ArticlePubMedGoogle Scholar
  44. Ley SH, Harris SB, Mamakeesick M, Noon T, Fiddler E, Gittelsohn J, Wolever TM, Connelly PW, Hegele RA, Zinman B, Hanley AJ. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an aboriginal community. CMAJ. 2009;180:617–24.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–78.View ArticlePubMedGoogle Scholar
  46. Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007;297:499–508.View ArticlePubMedGoogle Scholar
  47. He S, Wang S, Chen X, Jiang L, Peng Y, Li L, Wan L, Cui K. Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population. Metabolism. 2012;61:30–6.View ArticlePubMedGoogle Scholar
  48. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852–71.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Kraegen EW, Cooney GJ, Turner N. Muscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction. Proc Natl Acad Sci U S A. 2008;105:7627–8.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635–45.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, Wagenmakers AJ, Gilbert M, Karpe F, Frayn KN. Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes. 2007;56:168–76.View ArticlePubMedGoogle Scholar
  52. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes. 2001;50(Suppl 1):S118–21.View ArticlePubMedGoogle Scholar
  53. Drew BG, Rye KA, Duffy SJ, Barter P, Kingwell BA. The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol. 2012;8:237–45.View ArticlePubMedGoogle Scholar
  54. Brunham LR, Kruit JK, Verchere CB, Hayden MR. Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest. 2008;118:403–8.View ArticlePubMedPubMed CentralGoogle Scholar
  55. Rutti S, Ehses JA, Sibler RA, Prazak R, Rohrer L, Georgopoulos S, Meier DT, Niclauss N, Berney T, Donath MY, von Eckardstein A. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology. 2009;150:4521–30.View ArticlePubMedGoogle Scholar
  56. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev. 2008;29:777–822.View ArticlePubMedPubMed CentralGoogle Scholar
  57. Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32:1754–9.View ArticlePubMedGoogle Scholar
  58. Wang L, Cui L, Wang Y, Vaidya A, Chen S, Zhang C, Zhu Y, Li D, FB H, Wu S, Gao X. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study. Int J Epidemiol. 2015;44:689–99.View ArticlePubMedPubMed CentralGoogle Scholar
  59. Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D’Agostino RB Sr. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham heart study. Circulation. 2006;113:2914–8.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement